Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

11/27/2024 | Press release | Distributed by Public on 11/26/2024 22:08

VOLUNTARY ANNOUNCEMENT CORE PRODUCT SACITUZUMAB TIRUMOTECAN (sac TMT) APPROVED FOR MARKETING BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR 2L+ TNBC BASED ON OptiTROP[...]